Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Bactiguard Holding AB's net current asset value per share for the quarter that ended in Jun. 2026 was kr-2.92.
The historical rank and industry rank for Bactiguard Holding AB's Net Current Asset Value or its related term are showing as below:
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Bactiguard Holding AB was 1175.00. The lowest was 199.01. And the median was 662.50.
LTS:0QV2's Price-to-Net-Current-Asset-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 4.83 * Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
Bactiguard Holding AB (LTS:0QV2) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Bactiguard Holding AB Net Current Asset Value Related Terms
Bactiguard Holding AB Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Bactiguard Holding AB's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bactiguard Holding AB Net Current Asset Value Chart
LTS:0QV2 vs ABT, SYK, MDT: Net Current Asset Value Comparison
For the Medical Devices subindustry, Bactiguard Holding AB's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bactiguard Holding AB Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bactiguard Holding AB's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Bactiguard Holding AB's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of kr-2.92 mean?
Bactiguard Holding AB (LTS:0QV2) has a Net Current Asset Value of kr-2.92 as of Jun. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Bactiguard Holding AB and its competitors. Over the past decade, Bactiguard Holding AB's Net Current Asset Value has ranged from 199.01 to 1,175.00. According to the industry distribution chart, Bactiguard Holding AB ranks #999999 out of 569 companies in the Medical Devices & Instruments industry.
Is Bactiguard Holding AB's Net Current Asset Value too high?
Bactiguard Holding AB's current Net Current Asset Value is kr-2.92. Over the past 10 years, this metric has ranged from a low of 199.01 to a high of 1,175.00. Based on the distribution chart, Bactiguard Holding AB ranks #999999 out of 569 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bactiguard Holding AB has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's Net Current Asset Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bactiguard Holding AB ranks #999999 out of 569 companies for Net Current Asset Value. This places Bactiguard Holding AB in the lower half of its industry. The industry median Net Current Asset Value is 4.83. Historically, Bactiguard Holding AB's own Net Current Asset Value has ranged from 199.01 to 1,175.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 4.83, based on 569 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Bactiguard Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 4.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bactiguard Holding AB's current Net Current Asset Value is kr-2.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Bactiguard Holding AB (LTS:0QV2) has a current Net Current Asset Value of kr-2.92. The stock's GF Value™ is kr32.88, compared to a current price of kr17.25 — trading 47.5% below its estimated fair value. The current Net Current Asset Value is kr-2.92. Bactiguard Holding AB's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Bactiguard Holding AB (LTS:0QV2), the current Net Current Asset Value is kr-2.92 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bactiguard Holding AB (LTS:0QV2) Overvalued in 2026?
Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued.
The current stock price of kr17.25 is trading 47.5% below its estimated GF Value™ of kr32.88.
Key valuation signals for LTS:0QV2:
Net Current Asset Value: kr-2.92
GF Value™: kr32.88 vs. price of kr17.25 (47.5% below fair value)
No single metric tells the full story. See the LTS:0QV2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
61GF Score
Get the complete analysis for LTS:0QV2
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QV2 has been successfully added to your 
